Grant: Discovery Grants Program - Individual
Université de Sherbrooke
$28,050.00
New chemoselective peptide heterodimerization and cyclization reactions for the development of novel PET radiopharmaceuticals
EF 2010-11
Résumé
Positron emission tomography (PET) is a powerful diagnostic tool for the detection and follow-up of many medical conditions including cancer, heart problems and neurological disorders. The procedure requires the administration of a radiopharmaceutical prior to the PET scan and novel radiopharmaceuticals for the detection of specific medical problems are required to fully exploit this novel diagnostic tool. Peptide hormone receptors expressed in different medical conditions are of particular interest for the development of new, more specific radiopharmaceuticals. The object of this research program is to develop alternative synthetic approaches for the synthesis of a variety of novel peptide derivatives that can subsequently serve as tracers for improved,
site-specific radiopharmaceuticals for PET imaging. A second objective of the program is to develop rapid procedures to attach PET isotopes to the peptide analogs. To this end we propose to use our new peptide synthesis procedures to facilitate the incorporation of two readily available PET isotopes, fluorine-18 and copper-64. Thus, in addition to developing powerful, alternative synthetic procedures for the preparation and radiolabeling of peptide analogs, our program will provide a base for the design of new radiopharmaceuticals that will enlarge the number of medical conditions that can benefit from diagnostic PET imaging.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
341572-2008
Name nom
Guérin, Brigitte
Department département
Médecine nucléaire et radiobiologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
28050
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
3
Nb partie
3
Application title
New chemoselective peptide heterodimerization and cyclization reactions for the development of novel PET radiopharmaceuticals
Keyword
NSERC
Application summary
Positron emission tomography (PET) is a powerful diagnostic tool for the detection and follow-up of many medical conditions including cancer, heart problems and neurological disorders. The procedure requires the administration of a radiopharmaceutical prior to the PET scan and novel radiopharmaceuticals for the detection of specific medical problems are required to fully exploit this novel diagnostic tool. Peptide hormone receptors expressed in different medical conditions are of particular interest for the development of new, more specific radiopharmaceuticals. The object of this research program is to develop alternative synthetic approaches for the synthesis of a variety of novel peptide derivatives that can subsequently serve as tracers for improved,
site-specific radiopharmaceuticals for PET imaging. A second objective of the program is to develop rapid procedures to attach PET isotopes to the peptide analogs. To this end we propose to use our new peptide synthesis procedures to facilitate the incorporation of two readily available PET isotopes, fluorine-18 and copper-64. Thus, in addition to developing powerful, alternative synthetic procedures for the preparation and radiolabeling of peptide analogs, our program will provide a base for the design of new radiopharmaceuticals that will enlarge the number of medical conditions that can benefit from diagnostic PET imaging.